jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Super Advanced Diabetic Package

Diabetes

88 parameters

image

Report in 24Hrs

image

At Home

fastingrequire

Fasting Required

Details

Super advanced diabetic package covering insulin, sugar, glucose, iron, liver, kidney, lipid, thyroid, pancreas, blood, electrolytes, inflamation markers ,cardiac markers, vitamins, blood toxicity

₹4,299₹7,888

45% OFF

Parameters

  • List of Tests
    • Microalbumin
    • C-Peptide Fasting
    • Iron Studies
      • Iron
      • TIBC
      • Transferrin Saturation
    • Liver Function Test
      • Albumin
      • Alkaline Phosphatase
      • Bilirubin - Direct
      • Bilirubin - Indirect
      • Bilirubin - Total
      • AST/SGOT
      • ALT/SGPT
      • Total Protein
      • A/G Ratio
      • Gamma GT
      • Globulin
    • Kidney Profile
      • BUN
      • Calcium
      • Creatinine
      • Uric Acid
      • eGFR
      • BUN/Creatinine
      • Urea
    • Lipid Profile
      • Cholestrol/HDL
      • LDL/HDL
      • Non HDL
      • VLDL
      • Total Cholestrol
      • Triglycerides
      • HDL
      • LDL
    • Thyroid Profile
      • Total T3
      • Total T4
      • TSH
    • Hba1c
    • eAG
    • Insulin Fasting
    • Pancreatic Profile
      • Amylase
      • Lipase
    • CBC - Complete Hemogram
    • Serum Electrolytes
      • Na
      • K
      • Cl
    • Homosysteine
    • Lipoprotein Associated Phospholipase A2 (LP-PLA2)
    • Cardiac Markers
      • hs-CRP
      • Lipoprotein (a)
      • Apolipoprotein (A1)
      • Apolipoprotein (B)
      • Apo B/ Apo A1
    • Vitamin Profile
      • 25 - OH Vitamin D
      • Folic Acid
      • Vitamin B12
    • Blood Toxic Element Profile
      • Arsenic
      • Cadmium
      • Chromium
      • Cobalt
      • Lead
      • Mercury
      • Selenium
      • Barium
      • Caesium

Super Advanced Diabetic Package

  • Why is it done?
    • Comprehensive diabetes screening and monitoring to assess glycemic control, pancreatic function, and long-term complications
    • HbA1c and eAG measure average blood glucose over 2-3 months to assess glycemic control; C-Peptide Fasting and Insulin Fasting evaluate pancreatic beta cell function and insulin secretion capacity
    • Microalbumin detects early diabetic kidney damage (nephropathy) before clinical symptoms appear
    • Lipid Profile (8 components) and cardiac markers assess cardiovascular risk, a major complication in diabetic patients
    • Kidney Profile (7 components) monitors renal function and detects diabetic nephropathy progression
    • Liver Function Test (11 components) evaluates hepatic function and screens for non-alcoholic fatty liver disease (NAFLD), common in diabetics
    • Thyroid Profile (TSH, Total T3, Total T4) screens for thyroid disorders that frequently coexist with diabetes
    • CBC Complete Hemogram (28 parameters) detects anemia, infections, and blood disorders associated with diabetes
    • Pancreatic Profile (Amylase, Lipase) rules out pancreatitis and evaluates pancreatic enzyme levels
    • Iron Studies assess iron metabolism; diabetes increases iron absorption and oxidative stress risk
    • Serum Electrolytes (Na, K, Cl) monitor electrolyte balance crucial for diabetic patients on medication
    • Homocysteine, LP-PLA2, and Lipoprotein (a) identify additional cardiovascular risk factors; elevated homocysteine increases thrombotic risk
    • Vitamin Profile detects deficiencies in B12, Folic Acid, and Vitamin D; common in diabetics and metformin users
    • Blood Toxic Element Profile screens for heavy metal accumulation that can impair glucose metabolism and organ function
    • Indicated for newly diagnosed diabetes, routine annual monitoring in established diabetics, and when complications are suspected
  • Normal Range
    • Microalbumin: <30 mg/24 hours (normal); 30-299 mg/24 hours (microalbuminuria); ≥300 mg/24 hours (proteinuria)
    • C-Peptide Fasting: 0.8-3.1 ng/mL (0.26-1.03 nmol/L); indicates pancreatic beta cell reserve
    • Iron: 60-170 mcg/dL (10.7-30.4 µmol/L); TIBC: 250-425 mcg/dL (45-76 µmol/L); Transferrin Saturation: 20-50%
    • Albumin: 3.5-5.0 g/dL; Alkaline Phosphatase: 30-120 U/L; Total Bilirubin: 0.1-1.2 mg/dL; Direct Bilirubin: 0.0-0.3 mg/dL; Indirect Bilirubin: 0.1-1.0 mg/dL
    • AST (SGOT): 10-40 U/L; ALT (SGPT): 7-56 U/L; Total Protein: 6.0-8.3 g/dL; A/G Ratio: 1.0-2.5; Gamma GT: 0-65 U/L; Globulin: 2.0-3.5 g/dL
    • BUN: 7-20 mg/dL; Calcium: 8.5-10.5 mg/dL; Creatinine: 0.7-1.3 mg/dL (male), 0.6-1.1 mg/dL (female); Uric Acid: 3.5-7.2 mg/dL (male), 2.6-6.0 mg/dL (female); eGFR: >60 mL/min/1.73m²; BUN/Creatinine: 10-20; Urea: 2.5-7.1 mmol/L
    • Total Cholesterol: <200 mg/dL (desirable); HDL Cholesterol: >40 mg/dL (male), >50 mg/dL (female); LDL Cholesterol: <100 mg/dL (optimal); Triglycerides: <150 mg/dL; VLDL: <30 mg/dL; Cholesterol/HDL Ratio: <5.0; LDL/HDL Ratio: <3.0; Non-HDL: <130 mg/dL
    • TSH: 0.4-4.0 mIU/L; Total T3: 80-200 ng/dL; Total T4: 5.0-12 mcg/dL
    • HbA1c: <5.7% (good control); 5.7-6.4% (prediabetic range); ≥6.5% (diagnostic for diabetes); eAG: calculated from HbA1c, target <130 mg/dL for most diabetics
    • Insulin Fasting: 2-24 mIU/L (11.9-144 pmol/L); reflects pancreatic insulin production
    • Amylase: 30-110 U/L; Lipase: <60 U/L (varies by lab)
    • CBC parameters include: WBC: 4.5-11.0 K/uL; RBC: 4.5-5.9 M/uL (male), 4.1-5.1 M/uL (female); Hemoglobin: 13.5-17.5 g/dL (male), 12.0-15.5 g/dL (female); Hematocrit: 40-54% (male), 36-46% (female); MCV: 80-100 fL; Platelets: 150-400 K/uL; and differential count parameters
    • Sodium (Na): 136-145 mEq/L; Potassium (K): 3.5-5.0 mEq/L; Chloride (Cl): 98-107 mEq/L
    • Homocysteine: <15 µmol/L (normal); 15-30 µmol/L (moderate elevation); >30 µmol/L (high risk for thrombosis)
    • LP-PLA2: <200 ng/mL (low risk); 200-350 ng/mL (intermediate risk); >350 ng/mL (high cardiovascular risk)
    • hs-CRP: <1.0 mg/L (low risk); 1.0-3.0 mg/L (intermediate risk); >3.0 mg/L (high risk); Lipoprotein(a): <50 mg/dL (low risk); Apolipoprotein A1: >120 mg/dL (protective); Apolipoprotein B: <80 mg/dL; Apo B/Apo A1 Ratio: <0.6 (optimal)
    • 25-OH Vitamin D: >30 ng/mL (sufficient); 20-29 ng/mL (insufficient); <20 ng/mL (deficient); Folic Acid: >5.4 ng/mL; Vitamin B12: 200-900 pg/mL
    • Blood Toxic Elements (all should be <detectable limits): Arsenic: <2 mcg/L; Cadmium: <0.5 mcg/L; Chromium: <0.5 mcg/L; Cobalt: <0.1 mcg/L; Lead: <5 mcg/dL; Mercury: <5 mcg/L; Selenium: 70-150 mcg/L (adequate range); Barium: <1 mcg/L; Caesium: <0.1 mcg/L
  • Interpretation
    • Microalbumin - Elevated levels (30-299 mg/24h) indicate early diabetic nephropathy and increased cardiovascular risk; levels ≥300 mg/24h indicate overt proteinuria requiring aggressive treatment
    • C-Peptide Fasting - Elevated levels (>3.1 ng/mL) suggest insulin resistance or Type 2 diabetes; low levels (<0.8 ng/mL) indicate poor pancreatic beta cell function, suggesting Type 1 diabetes or advanced Type 2
    • Iron Studies - Elevated iron and transferrin saturation >50% increase oxidative stress and increase risk of cardiac disease and infection; low iron indicates anemia or iron deficiency; high TIBC suggests iron deficiency
    • Liver Function Tests - Elevated transaminases (AST, ALT) suggest hepatocellular injury or NAFLD; elevated bilirubin indicates cholestasis or hemolysis; low albumin suggests liver synthetic dysfunction; elevated Gamma GT suggests alcohol abuse or bile duct disease
    • Kidney Profile - Elevated creatinine and BUN indicate reduced renal function; eGFR <60 mL/min/1.73m² indicates chronic kidney disease; elevated uric acid increases gout risk; elevated calcium may indicate hyperparathyroidism
    • Lipid Profile - Elevated LDL and total cholesterol increase cardiovascular risk; low HDL (<40 mg/dL men, <50 mg/dL women) is atherogenic; elevated triglycerides (>150 mg/dL) indicate metabolic syndrome; ratios help assess overall cardiovascular risk
    • Thyroid Profile - Elevated TSH with low T4 suggests hypothyroidism; low TSH with elevated T4/T3 suggests hyperthyroidism; thyroid disorders are common in diabetics and affect glucose metabolism
    • HbA1c - Reflects average blood glucose over 8-12 weeks; <5.7% is normal; 5.7-6.4% indicates prediabetes risk; ≥6.5% diagnostic for diabetes; targets for most diabetics are 7-8% to reduce complications
    • eAG - Estimated Average Glucose calculated from HbA1c for better patient understanding; higher eAG correlates with increased complication risk
    • Insulin Fasting - Elevated fasting insulin (>12 mIU/L) indicates insulin resistance; low levels suggest inadequate pancreatic compensation in Type 2 diabetes
    • Pancreatic Profile - Elevated amylase and lipase suggest acute pancreatitis; chronic elevation may indicate chronic pancreatitis; important to monitor as diabetes increases pancreatitis risk
    • CBC - Low hemoglobin indicates anemia (common in diabetic kidney disease); elevated WBC suggests infection or inflammation; abnormal platelet counts affect bleeding risk
    • Serum Electrolytes - Low potassium (hypokalemia) requires intervention as it increases arrhythmia risk; low sodium (hyponatremia) may indicate SIADH; abnormal chloride reflects acid-base disorders
    • Homocysteine - Elevated homocysteine (>15 µmol/L) is independent cardiovascular risk factor; increases thrombosis and atherosclerosis risk; may respond to B vitamin supplementation
    • LP-PLA2 - Elevated levels (>200 ng/mL) indicate vascular inflammation and increased atherosclerosis risk independent of lipid levels
    • Cardiac Markers - hs-CRP elevation indicates systemic inflammation and increased MI risk; elevated Lipoprotein(a) (>50 mg/dL) indicates genetic predisposition to atherosclerosis; low Apo A1 is atherogenic; high Apo B indicates excess atherogenic particles
    • Vitamin D - Deficiency (<20 ng/mL) associates with increased diabetes risk and poor glycemic control; insufficiency (20-29 ng/mL) requires supplementation
    • Vitamin B12 - Low levels (<200 pg/mL) indicate deficiency common in metformin users; causes neuropathy and cognitive dysfunction
    • Folic Acid - Deficiency impairs glucose metabolism and increases homocysteine; commonly low in diabetics
    • Toxic Elements - Elevated lead impairs cognition and increases hypertension; cadmium damages kidneys; arsenic increases diabetes risk; mercury impairs neurological function; cobalt and chromium affect glucose metabolism
  • Associated Organs
    • Microalbumin - Kidneys (early diabetic nephropathy); identifies patients at risk for end-stage renal disease and cardiovascular events
    • C-Peptide and Insulin - Pancreas (beta cell function); assesses insulin-secreting capacity; helps distinguish Type 1 from Type 2 diabetes
    • Iron Studies - Liver, bone marrow, GI tract; excess iron increases cirrhosis risk and myocardial infarction risk in diabetics
    • Liver Function Tests - Liver; detects NAFLD (non-alcoholic fatty liver disease), cirrhosis, hepatitis, and cholestasis; diabetes increases NAFLD risk
    • Kidney Profile - Kidneys; assesses glomerular filtration and identifies chronic kidney disease; crucial for monitoring diabetic nephropathy
    • Lipid Profile - Cardiovascular system (arteries, heart); identifies atherosclerosis risk; diabetes increases cardiovascular events 2-4 fold
    • Thyroid Profile - Thyroid gland; identifies autoimmune thyroiditis and hyperthyroidism; thyroid dysfunction impairs glucose control
    • HbA1c/eAG - Pancreas, blood; reflects chronic hyperglycemia and predicts microvascular complications (neuropathy, retinopathy, nephropathy)
    • Pancreatic Profile - Pancreas; elevated enzymes indicate pancreatic inflammation; diabetes patients have increased acute pancreatitis risk
    • CBC - Bone marrow, blood vessels; detects anemia from chronic kidney disease, infections, and clotting disorders
    • Serum Electrolytes - Kidneys, heart, nerves; essential for cardiac rhythm, nerve conduction, and fluid balance
    • Homocysteine - Cardiovascular system, kidneys, nervous system; elevated levels increase thrombosis and neurological complications
    • LP-PLA2 - Cardiovascular system; indicates vascular inflammation independent of lipid profile; predicts atherosclerotic events
    • Cardiac Markers - Heart, blood vessels; assesses inflammation, thrombotic risk, and atherosclerosis burden
    • Vitamin Profile - Nervous system, bone, immune system; deficiencies cause peripheral neuropathy, immunosuppression, and osteoporosis
    • Toxic Elements - Multiple organs; accumulation damages kidneys, nervous system, liver, and heart; impairs glucose metabolism
  • Follow-up Tests
    • Microalbumin elevated - Follow with urine albumin-to-creatinine ratio (ACR), repeat urine microalbumin in 3-6 months; consider renal ultrasound and ACE inhibitor/ARB initiation
    • C-Peptide abnormal - Follow with HOMA-IR index calculation, repeat testing 3-6 months, consider oral glucose tolerance test (OGTT)
    • Iron studies abnormal - Repeat testing 2-4 weeks, consider ferritin level, transferrin saturation ratio; genetic testing for hemochromatosis if indicated
    • Liver enzymes elevated - Repeat LFTs in 2-4 weeks; ultrasound liver if persistently elevated; FibroScan for fibrosis assessment; rule out viral hepatitis with serologies
    • Kidney function abnormal - Repeat kidney profile monthly initially; urinalysis; renal ultrasound; consider endocrinology/nephrology referral; cystatin C if eGFR borderline
    • Abnormal lipids - Repeat lipid panel monthly; advanced lipid testing (sdLDL, Lp(a)); cardiac imaging if indicated; consider cardiology referral for high-risk patients
    • Thyroid abnormal - Repeat TSH and free T4 in 6-8 weeks; thyroid antibodies (TPO, thyroglobulin); consider endocrinology referral
    • HbA1c elevated - Repeat HbA1c every 3 months until target achieved; consider continuous glucose monitoring (CGM); home glucose monitoring; diabetes education intensification
    • Abnormal insulin/C-peptide - Calculate HOMA-IR (Homeostatic Model Assessment of Insulin Resistance); consider insulin tolerance testing; endocrinology consultation
    • Elevated pancreatic enzymes - Repeat amylase and lipase in 24-48 hours; abdominal ultrasound; consider CT abdomen; lipid panel; refer to gastroenterology if chronic pancreatitis suspected
    • CBC abnormal - Repeat CBC in 1-2 weeks; peripheral blood smear; reticulocyte count if anemia; bone marrow biopsy if indicated
    • Electrolyte abnormality - Repeat electrolytes in 24-48 hours; assess medications (diuretics, ACE-I, SGLT2i); adjust dosing; monitor closely
    • Elevated homocysteine - Repeat testing after B vitamin supplementation (B6, B12, folic acid); recheck in 2-3 months; cardiac assessment
    • LP-PLA2 or cardiac markers elevated - Consider coronary artery disease screening (EKG, stress test, calcium scoring); cardiology referral; advanced cardiac imaging
    • Vitamin deficiencies - Supplement with appropriate dose; recheck levels 2-3 months after supplementation; assess absorption issues; dietary counseling
    • Toxic elements elevated - Repeat testing to confirm; identify sources of exposure; chelation therapy may be considered for lead or mercury; occupational/environmental history
    • General recommendations - Repeat full Super Advanced Diabetic Package annually for stable diabetics; every 6 months for poorly controlled or newly diagnosed; more frequently if complications detected
  • Fasting Required?
    • YES - 8-12 hours fasting required for this comprehensive test package
    • Fasting duration: Ideally 12 hours overnight fasting; minimum 8 hours acceptable; perform blood collection in early morning between 7-9 AM
    • No food or beverage except water for 8-12 hours before test; water intake is permitted and encouraged
    • No alcohol consumption for 24 hours before testing as it affects liver enzymes and lipid levels
    • Medications: Continue regular medications with small sip of water unless specifically instructed otherwise; avoid NSAIDs and aspirin 48 hours prior
    • Insulin-dependent diabetics: Take morning insulin after blood collection to maintain glucose homeostasis
    • Avoid heavy exercise for 24 hours before testing as it affects lipid and muscle enzyme levels
    • Avoid smoking and caffeine for at least 12 hours before test as they affect various parameters including glucose and lipids
    • Avoid stress and anxiety 24 hours before testing as stress hormones elevate glucose, cortisol, and lipid levels
    • Maintain normal sleep pattern; avoid sleep deprivation as it affects glucose metabolism and inflammatory markers
    • Do not consume high-fat diet 24-48 hours before test; this affects triglyceride and lipid measurements
    • Avoid supplements and herbal remedies for 24 hours before test unless medically necessary
    • Women: Schedule test at same time of menstrual cycle for consistency as hormones affect glucose and lipid levels
    • Arrive 10-15 minutes early to rest after sitting for blood pressure normalization; take vital signs on seating
    • After blood collection: Eat a light meal or snack within 1-2 hours; diabetic patients should check blood glucose if symptomatic of hypoglycemia

How our test process works!

customers
customers